AmerisourceBergen stock plummets 9% alongside other companies...

12:50 EDT 3 Aug 2017 | Topix

Shares of the drug distributor fell alongside other companies affected by generic price deflation on Thursday, after Teva Pharmaceutical Industries Ltd. reported generics revenue that was below expectations and cut its 2017 adjusted EPS outlook. AmerisourceBergen said on its earnings call that generic deflation is a big headwind, hasn't yet eased from high single digits and that the trend may continue into fiscal 2018.

Original Article: AmerisourceBergen stock plummets 9% alongside other companies...


More From BioPortfolio on "AmerisourceBergen stock plummets 9% alongside other companies..."

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...